We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 456 results
  1. E1231 Alleviates Diabetic Cardiomyopathy by Regulating the Silent Information Regulator 1/Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α/Nuclear Factor Erythroid 2-Related Factor 2 Pathway

    We aimed to investigate the underlying function and mechanism of E1231 against diabetic cardiomyopathy (DCM). H9c2 cells were exposed to either 33...

    Yunxia Cui, Hongjun Lou, ... ** Gao in Pharmaceutical Chemistry Journal
    Article 01 May 2024
  2. Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis

    The proliferation, differentiation, and migration of neural precursor cells occur not only during embryonic development but also within distinct...

    Juhee Lim, Hyo In Kim, ... Hyun ** Choi in Archives of Pharmacal Research
    Article 17 June 2021
  3. A novel plausible mechanism of NSAIDs-induced apoptosis in cancer cells: the implication of proline oxidase and peroxisome proliferator-activated receptor

    Although pharmaco-epidemiological studies provided evidence for the anticancer potential of non-steroidal anti-inflammatory drugs (NSAIDs), the...

    Adam Kazberuk, Ilona Zareba, ... Arkadiusz Surazynski in Pharmacological Reports
    Article Open access 24 July 2020
  4. LJ-529, a partial peroxisome proliferator-activated receptor gamma (PPARγ) agonist and adenosine A3 receptor agonist, ameliorates elastase-induced pulmonary emphysema in mice

    Chronic obstructive pulmonary disease (COPD) is the leading cause of human death worldwide. Currently available therapies for COPD mainly relieve...

    Hye-** Boo, So Jung Park, ... Ho-Young Lee in Archives of Pharmacal Research
    Article 19 May 2020
  5. Oleuropein as a Therapeutic Agent for Non-alcoholic Fatty Liver Disease During Hepatitis C

    Hepatitis C is defined as an infection of hepatocytes by the hepatitis C virus that affects hepatocellular signaling pathways and can lead to...

    Mohammadjavad Sotoudeheian, SeyedAhmad Hoseini, ... Hamidreza Pazoki-Toroudi in Revista Brasileira de Farmacognosia
    Article 01 June 2023
  6. In-Silico Study, Preparation and Biological Evaluation of 99MTC-Mesalamine Complex as Radiotracer for Diagnostics and Monitoring of Ulcerative Colitis in Mice

    This work centralizes on pursuit ulcerative colitis localized in mice. High radiolabeling and purity were ensured during the formation of a...

    M. H. Sanad, S. F. A. Rizvi, ... A. B. Farag in Pharmaceutical Chemistry Journal
    Article 20 September 2022
  7. Using Liposomal and Intranasal Drugs and Pioglitazone for the Treatment and Prevention of Alzheimer’s Disease (Review)

    This review article provides information on the development of liposomal drug delivery systems to cross the blood(brain barrier (BBB). Information on...

    V. V. Veselov, N. N. Eroshchenko, ... A. E. Nosyrev in Pharmaceutical Chemistry Journal
    Article 15 April 2023
  8. Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight

    Alcoholic liver disease (ALD) refers to hepatic ailments induced by excessive alcohol intake. The pathogenesis of ALD comprises a complex interplay...

    Rania M. Salama, Samah S. Abbas, ... Sara A. El Wakeel in Archives of Pharmacal Research
    Article Open access 23 March 2023
  9. Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway

    Insulin signaling and lipid metabolism are disrupted by long-term consumption of a high-fat diet (HFD). This disruption can lead to insulin...

    Laongdao Thongnak, Nattavadee Pengrattanachot, ... Anusorn Lungkaphin in Archives of Pharmacal Research
    Article 26 March 2023
  10. Hyperoside attenuates pyrrolizidine alkaloids-induced liver injury by ameliorating TFEB-mediated mitochondrial dysfunction

    Pyrrolizidine alkaloids (PAs) are potent hepatotoxins that can cause liver damage. Hyperoside (Hyp), a natural flavonoid, can be extracted from...

    Jie Xu, Aizhen **ong, ... Li Yang in Archives of Pharmacal Research
    Article 01 August 2023
  11. Role of the β2-adrenergic receptor in podocyte injury and recovery

    Background

    Podocytes have a remarkable ability to recover from injury; however, little is known about the recovery mechanisms involved in this...

    Ehtesham Arif, Ashish K. Solanki, ... Joshua H. Lipschutz in Pharmacological Reports
    Article Open access 26 April 2024
  12. Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes

    Induction of the brown adipocyte-like phenotype in white adipocytes (fat browning) is considered a promising therapeutic strategy to treat obesity....

    Ho Seon Lee, Chan Uk Heo, ... Chang-Ik Choi in Archives of Pharmacal Research
    Article 25 February 2023
  13. Therapeutic Effects of Resveratrol in Inflammatory Bowel Diseases: Shedding Light on the Role of Cellular and Molecular Pathways

    Inflammatory bowel disease is a debilitating idiopathic inflammatory condition of the gastrointestinal tract. Generally, this illness contains two...

    Marjan Talebi, Mohsen Talebi, ... Saeed Samarghandian in Revista Brasileira de Farmacognosia
    Article 01 April 2022
  14. Anti-hepatic Fibrosis Potential of Ailanthone, A Quassinoid Isolated from Ailanthus altissima

    Ailanthone is an active ingredient isolated from Ailanthus altissima (Mill.) Swingle, Simaroubaceae, which is a traditional medicine widely used in...

    **ang Li, Qianqian Zhao, ... Siwang Wang in Revista Brasileira de Farmacognosia
    Article 02 December 2022
  15. The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus

    Type 2 diabetes mellitus (T2DM) is a persistent metabolic disorder marked by deficiencies in insulin secretion and/or function, affecting various...

    Wenwen Ding, **aoxue Yang, ... Ying Liu in Archives of Pharmacal Research
    Article 14 March 2024
  16. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a theoretical perspective

    Background

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes pulmonary injury or multiple-organ injury by various pathological...

    Seyed Hootan Hamidi, Sandhya Kadamboor Veethil, Seyedeh Harir Hamidi in Pharmacological Reports
    Article 21 April 2021
  17. Contribution of changes in the orexin system and energy sensors in the brain in depressive disorder - a study in an animal model

    Background

    Maternal elevated glucocorticoid levels during pregnancy can affect the develo** fetus, permanently altering the structure and function...

    Katarzyna Głombik, Magdalena Kukla-Bartoszek, ... Bogusława Budziszewska in Pharmacological Reports
    Article Open access 09 January 2024
  18. Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology

    Formyl peptide receptors (FPRs) belong to the family of seven-transmembrane G protein-coupled receptors. Among them, FPR2 is a low affinity receptor...

    Kinga Tylek, Ewa Trojan, ... Agnieszka Basta-Kaim in Pharmacological Reports
    Article Open access 08 June 2021
  19. Synthesis and Pharmacological Activity of 3-Phenoxybenzoic Acid Derivatives

    3-Phenoxybenzoic acid derivatives were synthesized. Their pharmacological activity was studied. Several compounds, in particular 2-cyanoprop-2-yl...

    A. A. Spasov, V. S. Lobasenko, ... T. K. Korchagina in Pharmaceutical Chemistry Journal
    Article 12 June 2020
  20. The effect of new atypical antipsychotic drugs on the expression of transcription factors regulating cytochrome P450 enzymes in rat liver

    Background

    Our recent studies showed that prolonged administration of novel atypical antipsychotics affected the expression and activity of cytochrome...

    Przemysław J. Danek, Władysława A. Daniel in Pharmacological Reports
    Article Open access 15 June 2024
Did you find what you were looking for? Share feedback.